浙江寰领医药科技

Zhejiang Huanling Pharmaceutical Technology is a biotechnology company focused on the research and development of innovative transdermal drug delivery systems, specifically dissolving microneedle technology. Based in Hangzhou, China, the company leverages its proprietary platform to develop painless and effective delivery methods for vaccines, peptides, and small molecules. Their platform technology addresses the limitations of traditional injections by providing a minimally invasive alternative that enhances drug stability and patient compliance. The company's pipeline includes programs targeting metabolic diseases like diabetes and obesity, as well as localized pain management and medical aesthetics. Huanling Pharma has successfully secured venture capital funding to advance its lead candidates through preclinical and clinical development.